NFKB1 and cancer: In-vivo studies of xenograft mouse model indicate that apigenin (20 and 50 μg/day, gavage) suppressed tumor growth, lowered cancer cells proliferation, and enhanced apoptosis, mediated with the inhibition of p-IKKα, NF-κB/p65 (Shukla et al., 2015).